As the CEO of EDBI since late 2008, what would you say have been the main developments of the agency during this time? EDBI is the…
In Conversation
Nine months ago you were appointed CEO of the company. What brought you to Dx assays? I think Dx Assays is a very interesting opportunity, which…
Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into…
What is the global R&D vision of Takeda, Japan’s largest pharmaceutical company that recently celebrated its 230th birthday? Takeda’s global R&D vision is committed to the…
What prompted you to found TriReme six years ago? I set up companies, so TriReme was not the first. The idea behind TriReme was to provide…
Singapore wants to be seen as a springboard for Asia, but that is a position that other countries in Asia would also like to hold. In…
Since the last time we had the pleasure of meeting you, 4 years ago, what have been the main developments and changes in the Singaporean pharmaceutical…
As a pioneering member of Arcasia, before it merged with JTC International and became what is Ascendas today, you know the history of the company very…
Central Asia, what is Central Asia in the BD perspective? For us, Central Asia includes all the countries in Asia, except Greater China, India and Japan.…
The company’s current corporate strategy includes a major focus on the Emerging Markets and Asia Pacific (EMAP) region. Concretely, what are the expectations and the main…
Please give us an overview of HOYA Surgical Optics and its operations. HOYA Surgical Optics is a global manufacturer of intraocular lenses (IOLs) — the artificial…
There has been much hype about emerging markets, especially those in Asia. How important are these markets for GE and what are your respective goals for…
